Rheumatology International

, Volume 37, Issue 9, pp 1527–1539 | Cite as

Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis

  • Fatemeh Heidari
  • Mahdi Afshari
  • Mahmood Moosazadeh
Epidemiology of RMD


This study aims to estimate the reliable prevalence of fibromyalgia using meta-analysis method. Available databanks were searched using appropriate keywords. According to the heterogeneity between the results (indicated by Cochrane and I square indices), random- or fixed-effects model was applied to combine the point prevalences. Meta-regression models were used to assess the suspected factors in the heterogeneity. In 65 selected papers, 81 evidences regarding prevalence of fibromyalgia among 3,609,810 subjects from general population and specific groups were investigated. The total prevalences (95% confidence intervals) of fibromyalgia among general population, women, men, patients referring to rheumatology and internal departments, patients with Irritable bowel syndrome (IBS), hemodialysis patients and those with type 2 diabetes mellitus were estimated as of 1.78% (1.65, 1.92), 3.98% (2.80, 5.20), 0.01% (−0.04, 0.06), 15.2% (13.6, 16.90), 12.9% (12.70, 13.10), 6.30% (4.60, 7.90) and 14.80% (11.10, 18.40), respectively. In addition, prevalence of fibromyalgia in specified groups varied from 3.90% in hemodialysis patients to 80% in patients suffering from Behcet syndrome. This meta-analysis showed that prevalence of fibromyalgia in general population was significantly lower than that in populations with some diseases.


Fibromyalgia Prevalence Meta-analysis Systematic review 

Supplementary material

296_2017_3725_MOESM1_ESM.doc (33 kb)
Supplementary material 1 (DOC 33 kb)


  1. 1.
    Naji A, Arab P (2006) Prevalence of fibromyalgia syndrome in patients referring to Shariati hospital, Terhan. Tehran Univ Med J 64(10):60–66Google Scholar
  2. 2.
    Topbas M, Cakirbay H, Gulec H, Akgol E, Ak I, Can G (2005) The prevalence of fibromyalgia in women aged 20–64 in Turkey. Scand J Rheumatol 34(2):140–144PubMedGoogle Scholar
  3. 3.
    Branco JC, Bannwarth B, Failde I, Carbonell JA, Blotman F, Spaeth M et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39(6):448–453CrossRefPubMedGoogle Scholar
  4. 4.
    Shakibi MR, Ata-pour J, Ramezani MA (2001) Prevalence of fibromyalgia in patients referring to Kerman rheumatology clinic from 1995 to 1998. J Kerman Univ Med Sci 8(4):220–225Google Scholar
  5. 5.
    Santos AMB, Burti JS, Lopes JB, Scazufca M, Marques AP, Pereira RMR (2010) Prevalence of fibromyalgia and chronic widespread pain in community-dwelling elderly subjects living in São Paulo, Brazil. Maturitas 67(3):251–255CrossRefPubMedGoogle Scholar
  6. 6.
    Croft P, Rigby A, Boswell R, Schollum J, Silman A (1993) The prevalence of chronic widespread pain in the general population. J Rheumatol 20(4):710–713PubMedGoogle Scholar
  7. 7.
    Bannwarth B, Blotman F, Roué-Le Lay K, Caubère J-P, André E, Taïeb C (2009) Fibromyalgia syndrome in the general population of France: a prevalence study. Joint Bone Spine 76(2):184–187CrossRefPubMedGoogle Scholar
  8. 8.
    White KP, Harth M, Speechley M, Ostbye T (1999) Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire. J Rheumatol 26(4):880–884PubMedGoogle Scholar
  9. 9.
    Pincus T, Castrejón I (2012) An evidence-based medical visit for patients with rheumatoid arthritis based on standard, quantitative scientific data from a patient MDHAQ and physician report. Bull NYU Hosp Jt Dis 70(2):73–94PubMedGoogle Scholar
  10. 10.
    Moosazadeh M, Lankarani KB, Afshari M (2016) Meta-analysis of the prevalence of Helicobacter pylori infection among children and adults of Iran. Int J Prev Med 7:48CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Haghshenas MR, Mousavi T, Moosazadeh M, Afshari M (2016) Human papillomavirus and breast cancer in Iran: a meta-analysis. Iran J Basic Med Sci 19(3):231–237PubMedPubMedCentralGoogle Scholar
  12. 12.
    Kelishadi R, Haghdoost AA, Moosazadeh M, Keikha M, Aliramezany M (2015) A systematic review and meta-analysis on screening lipid disorders in the pediatric age group. J Res Med Sci 20(12):1191–1199CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med 45(4):247–251CrossRefGoogle Scholar
  14. 14.
    Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558CrossRefPubMedGoogle Scholar
  15. 15.
    Ablin JN, Oren A, Cohen S, Aloush V, Buskila D, Elkayam O et al (2012) Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ). Clin Exp Rheumatol 30(6 Suppl 74):39–43PubMedGoogle Scholar
  16. 16.
    Almodovar R, Carmona L, Zarco P, Collantes E, Gonzalez C, Mulero J et al (2010) Fibromyalgia in patients with ankylosing spondylitis: prevalence and utility of the measures of activity, function and radiological damage. Clin Exp Rheumatol 28(6 Suppl 63):S33–S39PubMedGoogle Scholar
  17. 17.
    Andary MT, Wieting JM, Baer D, Naftulin S, Hallgren RC (2004) The prevalence of fibromyalgia in collegiate athletes. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis 10(6):323–325Google Scholar
  18. 18.
    Assumpcao A, Cavalcante AB, Capela CE, Sauer JF, Chalot SD, Pereira CA et al (2009) Prevalence of fibromyalgia in a low socioeconomic status population. BMC Musculoskelet Disord 10:64CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Barton A, Pal B, Whorwell PJ, Marshall D (1999) Increased prevalence of sicca complex and fibromyalgia in patients with irritable bowel syndrome. Am J Gastroenterol 94(7):1898–1901CrossRefPubMedGoogle Scholar
  20. 20.
    Bennett R (2005) The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 23(5):S154PubMedGoogle Scholar
  21. 21.
    Brill S, Ablin JN, Goor-Aryeh I, Hyat K, Slefer A, Buskila D (2012) Prevalence of fibromyalgia syndrome in patients referred to a tertiary pain clinic. J Investig Med Off Publ Am Fed Clin Res 60(4):685–688Google Scholar
  22. 22.
    Buskila D, Ablin JN, Ben-Zion I, Muntanu D, Shalev A, Sarzi-Puttini P et al (2009) A painful train of events: increased prevalence of fibromyalgia in survivors of a major train crash. Clin Exp Rheumatol 27(5 Suppl 56):S79–S85PubMedGoogle Scholar
  23. 23.
    Buskila D, Fefer P, Harman-Boehm I, Press J, Neumann L, Lunenfeld E et al (1993) Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women. J Rheumatol 20(12):2112–2115PubMedGoogle Scholar
  24. 24.
    Buskila D, Neumann L, Odes LR, Schleifer E, Depsames R, Abu-Shakra M (2001) The prevalence of musculoskeletal pain and fibromyalgia in patients hospitalized on internal medicine wards. Semin Arthritis Rheum 30(6):411–417CrossRefPubMedGoogle Scholar
  25. 25.
    Carranza-Lira S, Hernandez IB (2014) Prevalence of fibromyalgia in premenopausal and postmenopausal women and its relation to climacteric symptoms. Przeglad menopauzalny Menopause Rev 13(3):169–173CrossRefGoogle Scholar
  26. 26.
    Clark P, Burgos-Vargas R, Medina-Palma C, Lavielle P, Marina FF (1998) Prevalence of fibromyalgia in children: a clinical study of Mexican children. J Rheumatol 25(10):2009–2014PubMedGoogle Scholar
  27. 27.
    Cobankara V, Unal UO, Kaya A, Bozkurt AI, Ozturk MA (2011) The prevalence of fibromyalgia among textile workers in the city of Denizli in Turkey. Int J Rheum Dis 14(4):390–394CrossRefPubMedGoogle Scholar
  28. 28.
    Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA (2006) Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 6:26CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Couto CI, Natour J, Carvalho AB (2008) Fibromyalgia: its prevalence and impact on the quality of life on a hemodialyzed population. Hemodial Int Int Symp Home Hemodial 12(1):66–72CrossRefGoogle Scholar
  30. 30.
    Cruz BA, Catalan-Soares B, Proietti F (2006) Higher prevalence of fibromyalgia in patients infected with human T cell lymphotropic virus type I. J Rheumatol 33(11):2300–2303PubMedGoogle Scholar
  31. 31.
    Davatchi F, Tehrani Banihashemi A, Gholami J, Faezi ST, Forouzanfar MH, Salesi M et al (2009) The prevalence of musculoskeletal complaints in a rural area in Iran: a WHO-ILAR COPCORD study (stage 1, rural study) in Iran. Clin Rheumatol 28(11):1267–1274CrossRefPubMedGoogle Scholar
  32. 32.
    Demir SE, Aytekin E, Karacan I, Aydin T, Kavadar GD (2014) The prevalence of fibromyalgia among patients with cervical radiculopathy due to cervical disc herniation: a pilot study. J Back Musculoskelet Rehabil 27(2):167–171CrossRefPubMedGoogle Scholar
  33. 33.
    Durmaz Y, Alayli G, Canbaz S, Zahiroglu Y, Bilgici A, Ilhanli I et al (2013) Prevalence of juvenile fibromyalgia syndrome in an urban population of Turkish adolescents: impact on depressive symptoms, quality of life and school performance. Chin Med J 126(19):3705–3711PubMedGoogle Scholar
  34. 34.
    Forseth KO, Gran JT (1992) The prevalence of fibromyalgia among women aged 20–49 years in Arendal, Norway. Scand J Rheumatol 21(2):74–78CrossRefPubMedGoogle Scholar
  35. 35.
    Goulding C, O’Connell P, Murray FE (2001) Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition. Eur J Gastroenterol Hepatol 13(5):507–511CrossRefPubMedGoogle Scholar
  36. 36.
    Harbeck B, Sufke S, Harten P, Haas CS, Lehnert H, Monig H (2013) High prevalence of fibromyalgia-associated symptoms in patients with hypothalamic-pituitary disorders. Clin Exp Rheumatol 31(6 Suppl 79):S16–S21PubMedGoogle Scholar
  37. 37.
    Harvey CK (1993) Fibromyalgia. Part II. Prevalence in the podiatric patient population. J Am Podiatr Med Assoc 83(7):416–417CrossRefPubMedGoogle Scholar
  38. 38.
    Haviland MG, Banta JE, Przekop P (2011) Fibromyalgia: prevalence, course, and co-morbidities in hospitalized patients in the United States, 1999–2007. Clin Exp Rheumatol 29(6 Suppl 69):S79–S87PubMedGoogle Scholar
  39. 39.
    Howard KJ, Mayer TG, Neblett R, Perez Y, Cohen H, Gatchel RJ (2010) Fibromyalgia syndrome in chronic disabling occupational musculoskeletal disorders: prevalence, risk factors, and posttreatment outcomes. J Occup Environ Med Am Coll Occup Environ Med 52(12):1186–1191CrossRefGoogle Scholar
  40. 40.
    Ifergane G, Buskila D, Simiseshvely N, Zeev K, Cohen H (2006) Prevalence of fibromyalgia syndrome in migraine patients. Cephalalgia Int J Headache 26(4):451–456CrossRefGoogle Scholar
  41. 41.
    Jones GT, Atzeni F, Beasley M, Fluss E, Sarzi-Puttini P, Macfarlane GJ (2015) The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol (Hoboken, NJ) 67(2):568–575CrossRefGoogle Scholar
  42. 42.
    Kim C, Kim H, Kim J (2012) Prevalence of chronic widespread pain and fibromyalgia syndrome: a Korean hospital-based study. Rheumatol Int 32(11):3435–3442CrossRefPubMedGoogle Scholar
  43. 43.
    Kucuksen S, Genc E, Yilmaz H, Salli A, Gezer IA, Karahan AY et al (2013) The prevalence of fibromyalgia and its relation with headache characteristics in episodic migraine. Clin Rheumatol 32(7):983–990CrossRefPubMedGoogle Scholar
  44. 44.
    Leblebici B, Ozelsancak R, Yilmaz EE, Doruk P (2016) Fibromyalgia syndrome in Turkish hemodialysis patients. Hemodial Int Int Symp Home Hemodial 20(1):106–110CrossRefGoogle Scholar
  45. 45.
    Lindell L, Bergman S, Petersson IF, Jacobsson LT, Herrstrom P (2000) Prevalence of fibromyalgia and chronic widespread pain. Scand J Prim Health Care 18(3):149–153CrossRefPubMedGoogle Scholar
  46. 46.
    Lundberg G, Gerdle B (2002) Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. J Rheumatol 29(3):603–613PubMedGoogle Scholar
  47. 47.
    Okumus M, Parpucu H, Kocaoglu S, Ceceli E, Duranay M, Borman P (2012) The frequency of fibromyalgia syndrome and the quality of life in patients with peritoneal dialysis. Open J Rheumatol Autoimmune Dis 2(4):88–93CrossRefGoogle Scholar
  48. 48.
    Mäkelä M, Heliövaara M (1991) Prevalence of primary fibromyalgia in the Finnish population. BMJ Br Med J 303(6796):216–219CrossRefGoogle Scholar
  49. 49.
    Marrie RA, Yu BN, Leung S, Elliott L, Warren S, Wolfson C et al (2012) The incidence and prevalence of fibromyalgia are higher in multiple sclerosis than the general population: a population-based study. Multiple Scler Relat Disord 1(4):162–167CrossRefGoogle Scholar
  50. 50.
    Mas AJ, Carmona L, Valverde M, Ribas B (2008) Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol 26(4):519–526PubMedGoogle Scholar
  51. 51.
    Melikoglu M, Melikoglu MA (2013) The prevalence of fibromyalgia in patients with Behcet’s disease and its relation with disease activity. Rheumatol Int 33(5):1219–1222CrossRefPubMedGoogle Scholar
  52. 52.
    Middleton GD, McFarlin JE, Lipsky PE (1994) The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37(8):1181–1188CrossRefPubMedGoogle Scholar
  53. 53.
    Guermazi M, Ghroubi S, Sellami M, Elleuch M, Feki H, André E et al (2008) Fibromyalgia prevalence in TUNISIA. Tunis Med 86(9):806–811PubMedGoogle Scholar
  54. 54.
    Mohammad A, Carey JJ, Storan E, Scarry M, Coughlan RJ, Lee JM (2012) Prevalence of fibromyalgia among patients with chronic hepatitis C infection: relationship to viral characteristics and quality of life. J Clin Gastroenterol 46(5):407–412CrossRefPubMedGoogle Scholar
  55. 55.
    Mohammad A, Carey JJ, Storan E, Scarry M, Coughlan RJ, Lee JM (2013) High prevalence of fibromyalgia in patients with HFE-related hereditary hemochromatosis. J Clin Gastroenterol 47(6):559–564CrossRefPubMedGoogle Scholar
  56. 56.
    Nunes FR, Ferreira JM, Bahamondes L (2014) Prevalence of fibromyalgia and quality of life in women with and without endometriosis. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol 30(4):307–310CrossRefGoogle Scholar
  57. 57.
    Ozsahin M, Gonen I, Ermis F, Oktay M, Besir FH, Kutlucan A et al (2013) The prevalence of fibromyalgia among patients with hepatitis B virus infection. Int J Clin Exp Med 6(9):804–808PubMedPubMedCentralGoogle Scholar
  58. 58.
    Patucchi E, Fatati G, Puxeddu A, Coaccioli S (2003) Prevalence of fibromyalgia in diabetes mellitus and obesity. Recenti Prog Med 94(4):163–165PubMedGoogle Scholar
  59. 59.
    Perrot S, Vicaut E, Servant D, Ravaud P (2011) Prevalence of fibromyalgia in France: a multi-step study research combining national screening and clinical confirmation: the DEFI study (Determination of Epidemiology of FIbromyalgia). BMC Musculoskelet Disord 12:224CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Prescott E, Kjoller M, Jacobsen S, Bulow PM, Danneskiold-Samsoe B, Kamper-Jorgensen F (1993) Fibromyalgia in the adult Danish population: I. A prevalence study. Scand J Rheumatol 22(5):233–237CrossRefPubMedGoogle Scholar
  61. 61.
    Rusu C, Gee ME, Lagace C, Parlor M (2015) Chronic fatigue syndrome and fibromyalgia in Canada: prevalence and associations with six health status indicators. Health Promot Chronic Dis Prevent Canada Res Policy Pract 35(1):3–11CrossRefGoogle Scholar
  62. 62.
    Saa’d S, Many A, Jacob G, Ablin JN (2013) High prevalence of fibromyalgia symptoms among healthy full-term pregnant women. Rheumatol Int 33(6):1555–1560CrossRefPubMedGoogle Scholar
  63. 63.
    Samimagham H, Haghighi A, Tayebi M, Jenabi A, Arabi M, Kianmehr N (2014) Prevalence of fibromyalgia in hemodialysis patients. Iran J Kidney Dis 8(3):236–239PubMedGoogle Scholar
  64. 64.
    Sauer K, Kemper C, Glaeske G (2011) Fibromyalgia syndrome: prevalence, pharmacological and non-pharmacological interventions in outpatient health care. An analysis of statutory health insurance data. Joint Bone Spine revue du rhumatisme 78(1):80–84CrossRefGoogle Scholar
  65. 65.
    Sperber AD, Atzmon Y, Neumann L, Weisberg I, Shalit Y, Abu-Shakrah M et al (1999) Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications. Am J Gastroenterol 94(12):3541–3546CrossRefPubMedGoogle Scholar
  66. 66.
    Thune PO (2005) The prevalence of fibromyalgia among patients with psoriasis. Acta Dermato-venereologica 85(1):33–37CrossRefPubMedGoogle Scholar
  67. 67.
    Toda K (2007) The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol 36(2):140–144CrossRefPubMedGoogle Scholar
  68. 68.
    Vallejo M, Martínez-Martínez L-A, Grijalva-Quijada S, Olguín-Ruvalcaba H-M, Salas E, Hermosillo AG et al (2013) Prevalence of fibromyalgia in vasovagal syncope. JCR J Clin Rheumatol 19(3):111–114CrossRefPubMedGoogle Scholar
  69. 69.
    Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res 65(5):786–792CrossRefGoogle Scholar
  70. 70.
    Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F (2015) The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS One 10(9):e0138024CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Wolak T, Weitzman S, Harman-Boehm I, Friger M, Sukenik S (2001) Prevalence of fibromyalgia in type 2 diabetes mellitus. Harefuah 140(11):1006–9, 120, 119Google Scholar
  72. 72.
    Wolfe F, Brahler E, Hinz A, Hauser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 65(5):777–785CrossRefGoogle Scholar
  73. 73.
    Yanmaz MN, Mert M, Korkmaz M (2012) The prevalence of fibromyalgia syndrome in a group of patients with diabetes mellitus. Rheumatol Int 32(4):871–874CrossRefPubMedGoogle Scholar
  74. 74.
    Yener M, Erturan I, Ceyhan AM, Inal EE, Kazanoglu OO (2013) The evaluation of prevalence of fibromyalgia in patients with chronic urticaria. Med Sci Monit Int Med J Exp Clin Res 19:757–761Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Student Research Committee, School of Nursing and MidwiferyMazandaran University of Medical SciencesSariIran
  2. 2.Department of Community MedicineZabol University of Medical SciencesZabolIran
  3. 3.Health Sciences Research Center, Addiction InstituteMazandaran University of Medical SciencesSariIran

Personalised recommendations